These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23229639)

  • 21. Putative cholesterol-binding sites in human immunodeficiency virus (HIV) coreceptors CXCR4 and CCR5.
    Zhukovsky MA; Lee PH; Ott A; Helms V
    Proteins; 2013 Apr; 81(4):555-67. PubMed ID: 23161741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.
    Dogo-Isonagie C; Lam S; Gustchina E; Acharya P; Yang Y; Shahzad-ul-Hussan S; Clore GM; Kwong PD; Bewley CA
    J Biol Chem; 2012 Apr; 287(18):15076-86. PubMed ID: 22403408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMR-based approach to measure the free energy of transmembrane helix-helix interactions.
    Mineev KS; Lesovoy DM; Usmanova DR; Goncharuk SA; Shulepko MA; Lyukmanova EN; Kirpichnikov MP; Bocharov EV; Arseniev AS
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):164-72. PubMed ID: 24036227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition of RANTES by extracellular parts of the CCR5 receptor.
    Duma L; Häussinger D; Rogowski M; Lusso P; Grzesiek S
    J Mol Biol; 2007 Jan; 365(4):1063-75. PubMed ID: 17101151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short communication: identification of the conformational requirement for the specificities of coreceptors for human and simian immunodeficiency viruses.
    Shimizu N; Tanaka A; Jinno-Oue A; Mori T; Ohtsuki T; Hoshino H
    AIDS Res Hum Retroviruses; 2010 Mar; 26(3):321-8. PubMed ID: 20334567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allovalency observed by transferred NOE: interactions of sulfated tyrosine residues in the N-terminal segment of CCR5 with the CCL5 chemokine.
    Kessler N; Akabayov SR; Moseri A; Cohen LS; Sakhapov D; Bolton D; Fridman B; Kay LE; Naider F; Anglister J
    FEBS J; 2021 Mar; 288(5):1648-1663. PubMed ID: 32814359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Capture and reconstitution of G protein-coupled receptors on a biosensor surface.
    Stenlund P; Babcock GJ; Sodroski J; Myszka DG
    Anal Biochem; 2003 May; 316(2):243-50. PubMed ID: 12711346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of structure, dynamics, and detergent interactions of the anti-HIV chemokine variant 5P12-RANTES.
    Wiktor M; Hartley O; Grzesiek S
    Biophys J; 2013 Dec; 105(11):2586-97. PubMed ID: 24314089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
    Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR
    J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elucidation of the CCR1- and CCR5-binding modes of MIP-1α by application of an NMR spectra reconstruction method to the transferred cross-saturation experiments.
    Yoshiura C; Ueda T; Kofuku Y; Matsumoto M; Okude J; Kondo K; Shiraishi Y; Shimada I
    J Biomol NMR; 2015 Dec; 63(4):333-340. PubMed ID: 26472202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and computational support for the binding stability of a new CCR5/CXCR4 dual tropic inhibitor: Computational design of a CCR5/CXCR4 drug.
    Taylor CA; Miller BR; Parish CA
    J Mol Graph Model; 2017 Aug; 75():71-79. PubMed ID: 28575798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking.
    Arumugam K; Crouzy S; Chevigne A; Seguin-Devaux C; Schmit JC
    J Biomol Struct Dyn; 2014; 32(8):1274-89. PubMed ID: 23869548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function.
    Lee B; Sharron M; Blanpain C; Doranz BJ; Vakili J; Setoh P; Berg E; Liu G; Guy HR; Durell SR; Parmentier M; Chang CN; Price K; Tsang M; Doms RW
    J Biol Chem; 1999 Apr; 274(14):9617-26. PubMed ID: 10092648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCR4-CCR5: a couple modulating T cell functions.
    Contento RL; Molon B; Boularan C; Pozzan T; Manes S; Marullo S; Viola A
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10101-6. PubMed ID: 18632580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody epitopes on g protein-coupled receptors mapped with genetically encoded photoactivatable cross-linkers.
    Ray-Saha S; Huber T; Sakmar TP
    Biochemistry; 2014 Mar; 53(8):1302-10. PubMed ID: 24490954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large multiple transmembrane domain fragments of a G protein-coupled receptor: biosynthesis, purification, and biophysical studies.
    Potetinova Z; Tantry S; Cohen LS; Caroccia KE; Arshava B; Becker JM; Naider F
    Biopolymers; 2012; 98(5):485-500. PubMed ID: 23203693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions.
    Abayev M; Moseri A; Tchaicheeyan O; Kessler N; Arshava B; Naider F; Scherf T; Anglister J
    FEBS J; 2015 May; 282(10):1906-1921. PubMed ID: 25703038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
    Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P
    Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity.
    Blanpain C; Lee B; Vakili J; Doranz BJ; Govaerts C; Migeotte I; Sharron M; Dupriez V; Vassart G; Doms RW; Parmentier M
    J Biol Chem; 1999 Jul; 274(27):18902-8. PubMed ID: 10383387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.